{{Rsnum
|rsid=116840786
|Chromosome=3
|Orientation=plus
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=CAV3
|position=8733962
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=CAV3,SSUH2
}}{{omim
|id=601253
|rsnum=116840786
|variant=0012
}}{{ClinVar
|rsid=116840786
|Reversed=0
|FwdREF=C
|FwdALT=A,T
|REF=C
|ALT=A,T
|RSPOS=8775648
|CHROM=3
|dbSNPBuildID=132
|SSR=0
|SAO=1
|VP=0x050168000000000002110100
|GENEINFO=CAV3:859
|GENE_NAME=CAV3
|GENE_ID=859
|WGT=0
|VC=SNV
|CLNALLE=2
|CLNHGVS=NC_000003.11:g.8775648C>T
|CLNORIGIN=1
|CLNSRCID=
CAV3_00013; 601253.0012
|CLNSIG=5
|CLNCUI=
|CLNACC=
RCV000008784.1; RCV000024389.1
|Tags=PM;PMC;SLO;OTHERKG;LSD;OM
|CLNDBN=Creatine phosphokinase, elevated serum; not provided
|CLNDSDB=GeneReviews:MedGen:OMIM
|CLNDSDBID=NBK1385:C0241005:123320
|CLNSRC=Leiden Muscular Dystrophy pages (CAV3); OMIM Allelic Variant
|Disease=Creatine phosphokinase; not provided
}}{{PMID Auto
|PMID=12082049
|Title=Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene.
|OA=1
}}

{{PMID Auto
|PMID=14663034
|Title=A CAV3 microdeletion differentially affects skeletal muscle and myocardium.
}}

{{PMID Auto
|PMID=14749532
|Title=Dysferlin in a hyperCKaemic patient with caveolin 3 mutation and in C2C12 cells after p38 MAP kinase inhibition.
}}